These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 8639795

  • 1. Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.
    Van den Berg D, Wessman M, Murray L, Tong J, Chen B, Chen S, Simonetti D, King J, Yamasaki G, DiGiusto R, Gearing D, Reading C.
    Blood; 1996 May 15; 87(10):4348-57. PubMed ID: 8639795
    [Abstract] [Full Text] [Related]

  • 2. Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood.
    Murray L, Chen B, Galy A, Chen S, Tushinski R, Uchida N, Negrin R, Tricot G, Jagannath S, Vesole D.
    Blood; 1995 Jan 15; 85(2):368-78. PubMed ID: 7529060
    [Abstract] [Full Text] [Related]

  • 3. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM, Chimirri F, Podestà M, Pitto A, Piaggio G, Dejana A, Lerma E, Pollicardo N, Vassallo F, Soracco M, Benvenuto F, Valbonesi M, Carlier P, Vimercati R, Prencipe E, Gatti AM, Ferrara RA, Incagliato M, Florio G, Frassoni F.
    Bone Marrow Transplant; 1996 Feb 15; 17(2):201-5. PubMed ID: 8640167
    [Abstract] [Full Text] [Related]

  • 4. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia.
    Carella AM, Podesta M, Frassoni F, Raffo MR, Pollicardo N, Pungolino E, Vimercati R, Sessarego M, Parodi C, Rabitti C.
    Bone Marrow Transplant; 1993 Sep 15; 12(3):267-71. PubMed ID: 7694724
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Analysis of human hematopoietic stem cell populations.
    Murray L, DiGiusto D, Chen B, Chen S, Combs J, Conti A, Galy A, Negrin R, Tricot G, Tsukamoto A.
    Blood Cells; 1994 Sep 15; 20(2-3):364-9; discussion 369-70. PubMed ID: 7538340
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CD34+Thy-1+Lin- stem cells from mobilized peripheral blood.
    Murray LJ, Tsukamoto A, Hoffman R.
    Leuk Lymphoma; 1996 Jun 15; 22(1-2):37-42, follow. 186, color plate I. PubMed ID: 8724526
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo.
    Young JC, Lin K, Hansteen G, Travis M, Murray LJ, Jaing L, Scollay R, Hill BL.
    Exp Hematol; 1999 Jun 15; 27(6):994-1003. PubMed ID: 10378888
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cells.
    Talpaz M, Kantarjian H, Liang J, Calvert L, Hamer J, Tibbits P, Durett A, Claxton D, Giralt S, Khouri I.
    Blood; 1995 Jun 01; 85(11):3257-63. PubMed ID: 7756658
    [Abstract] [Full Text] [Related]

  • 13. Identification of CD34+ subsets after glycoprotease selection: engraftment of CD34+Thy-1+Lin- stem cells in fetal sheep.
    Sutherland DR, Yeo EL, Stewart AK, Nayar R, DiGiusto R, Zanjani E, Hoffman R, Murray LJ.
    Exp Hematol; 1996 Jun 01; 24(7):795-806. PubMed ID: 8647230
    [Abstract] [Full Text] [Related]

  • 14. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.
    Verfaillie CM, Bhatia R, Miller W, Mortari F, Roy V, Burger S, McCullough J, Stieglbauer K, Dewald G, Heimfeld S, Miller JS, McGlave PB.
    Blood; 1996 Jun 01; 87(11):4770-9. PubMed ID: 8639848
    [Abstract] [Full Text] [Related]

  • 15. The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: an in vivo model of chronic myelogenous leukemia biology.
    Dazzi F, Capelli D, Hasserjian R, Cotter F, Corbo M, Poletti A, Chinswangwatanakul W, Goldman JM, Gordon MY.
    Blood; 1998 Aug 15; 92(4):1390-6. PubMed ID: 9694728
    [Abstract] [Full Text] [Related]

  • 16. Idarubicin, intermediate-dose cytarabine, etoposide, and granulocyte-colony-stimulating factor are able to recruit CD34+/HLA-DR- cells during early hematopoietic recovery in accelerated and chronic phases of chronic myeloid leukemia.
    Carella AM, Frassoni F, Podestá M, Pungolino E, Pollicardo N, Ferrero R, Soracco M.
    J Hematother; 1994 Aug 15; 3(3):199-202. PubMed ID: 7530135
    [Abstract] [Full Text] [Related]

  • 17. Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin- cells with preserved ability to engraft SCID-hu bone.
    Luens KM, Travis MA, Chen BP, Hill BL, Scollay R, Murray LJ.
    Blood; 1998 Feb 15; 91(4):1206-15. PubMed ID: 9454750
    [Abstract] [Full Text] [Related]

  • 18. Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities.
    Uchida N, Combs J, Chen S, Zanjani E, Hoffman R, Tsukamoto A.
    Blood; 1996 Aug 15; 88(4):1297-305. PubMed ID: 8695847
    [Abstract] [Full Text] [Related]

  • 19. Cytokine-mobilized peripheral blood CD34+Thy-1+Lin- human hematopoietic stem cells as target cells for transplantation-based gene therapy.
    Chen BP, Fraser C, Reading C, Murray L, Uchida N, Galy A, Sasaki D, Tricot G, Jagannath S, Barlogie B.
    Leukemia; 1995 Oct 15; 9 Suppl 1():S17-25. PubMed ID: 7475307
    [Abstract] [Full Text] [Related]

  • 20. Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia.
    Boqué C, Petit J, Sarrá J, Cancelas JA, Muñoz J, Español JI, de la Banda E, Aventin A, Berlanga J, Ferrá C, Amill B, Torrico C, Azqueta C, Llucià M, García J, Grañena A.
    Bone Marrow Transplant; 1996 Nov 15; 18(5):879-84. PubMed ID: 8932840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.